- Fecal Incontinence
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Three-Year Cost-effectiveness Model for Non-Animal Stabilized Hyaluronic Acid and Dextranomer Copolymer Compared With Sacral Nerve Stimulation After Conservative Therapy for the Management of Fecal Incontinence
Don't miss out! Sign-up now to stay up to date on all the latest GI News and CME offerings from the Gastrointestinal Health Foundation.